
    
      The main hypothesis of the trial is that in-situ configuration of bilateral internal thoracic
      arteries is superior than Y-graft configuration for MACCE (mortality, myocardial infarction,
      repeat revascularization, stroke) during mid-term follow-up in patients with CAD who is
      shedueled for CABG.
    
  